Contents -- Preface -- Chapter 1: Family planning-expanding the choices -- As the end-users see it -- Contraceptive methods-selecting, staying, stopping, switching -- Safety of existing family planning methods -- The safety of implants -- The safety of progestin-only contraceptives -- The safety of intrauterine devices (IUDs) -- The safety of vasectomy -- Efficacy of existing family planning methods -- The effectiveness of the female condom -- Expanding choice through new or better methods -- Emergency contraception -- Male hormonal contraceptives -- Immunocontraception for women -- Boxes -- 1.1. Endometrial bleeding-back to basics -- 1.2. Team work for implantation research -- 1.3. Intrauterine devices-any time -- Figures -- 1.1. Percentages of women discontinuing use of contraceptive methods within one year of starting -- 1.2. Percentage of men who have undergone vasectomy in New Zealand, by age-group -- 1.3. Countries using levonorgestrel alone for emergency contraception -- 1.4. Effect on pregnancy rates of delay in taking 10 mg or 25 mg of mifepristone after unprotected sexual intercourse (data from a multicentre study in China) -- 1.5. Sperm concentrations in men receiving testosterone undecanoate during a multicentre trial in China -- 1.6. Sperm concentrations in men receiving testosterone undecanoate (TU), either alone or with depot-medroxyprogesterone acetate (DMPA), during a trial in Indonesia -- Tables -- 1.1. The cumulative ten-year probability (as of June 2001), expressed as a percentage, of a woman discontinuing the TCu-380A and Multiload-375 intrauterine devices, by reason for discontinuing -- 1.2. The cumulative six-year probability (as of December 2001), expressed as a percentage, of a woman discontinuing the TCu-380A intrauterine device and the Mirena levonorgestrel-releasing device -- Chapter 2: Making pregnancy safer.

Improving maternal health -- Preventing eclampsia -- Identifying the most effective antenatal care strategy -- Reducing postpartum haemorrhage -- Reducing unnecessary caesarean sections -- Measuring maternal mortality and its causes -- Boxes -- 2.1. The best evidence at a click -- Figures -- 2.1. Number of subscriptions, by WHO region, to the WHO Reproductive Health Library during the reporting biennium -- Tables -- 2.1. Causes of maternal and neonatal deaths, and principal interventions required -- Chapter 3: Preventing reproductive tract infections -- Mapping the prevalence of reproductive tract infections -- Preventing reproductive tract infections -- Condoms for men -- Condoms for women -- Microbicides and spermicides -- Human papillomavirus and cervical cancer -- Preventing HIV infection -- Boxes -- 3.1. Preventing mother-to-child transmission of HIV-an expert view -- Tables -- 3.1. Estimated annual incidence of curable sexually transmitted infections worldwide for 1999 (the latest year for which reliable data are available) -- 3.2. Estimated annual incidence and incidence rate of curable sexually transmitted infections in the 15-49-year age-group by region and worldwide for 1999 (the latest year for which reliable data are available) -- 3.3. Rate (%) of mother-to-child transmission of HIV in relation to breastfeeding -- Chapter 4: Preventing unsafe abortion -- Safe abortion everywhere-without surgery -- The dynamics and determinants of abortion -- Family planning and preference for male babies -- Medicine vs surgery -- Emergency contraception vs abortion -- Legal constraints -- Physicians vs non-physicians -- Boxes -- 4.1. Smaller is better for medical abortion -- Tables -- 4.1. Preferences between medical and surgical abortion among 400 women with experience of both methods, interviewed in Tianjin, China.

Chapter 5: Exploring adolescent reproductive health -- Risky sexual behaviour -- Adolescents in vulnerable settings -- Unwanted or non-consensual sexual activity -- Consequences of risky sexual behaviour -- Obstacles to seeking care -- Figures -- 5.1. Percentages of adolescents reporting sexual coercion in a study in Nigeria -- Chapter 6: Cooperating with countries -- Working with regions -- Africa and the Eastern Mediterranean -- The Americas -- Asia and the Pacific -- Eastern and Central Europe -- Working with countries -- Boxes -- 6.1. Grants for building research capacity -- 6.2. Workshops debate ethics -- 6.3. Female genital mutilation -- 6.4. A patient path from research to public policy -- 6.5. Countries using the HRP strategic approach -- 6.6. Women's and men's rights in reproductive health -- Figures -- 6.1. During the 2000-2001 biennium, 123 research centres in 59 countries (shaded in this map) participated in HRP activities and/or received some form of support from HRP. Together they make up HRP's global research network -- 6.2. Estimated prevalence rates of female genital mutilation in Africa -- 6.3. A "systems framework", that HRP has borrowed from business management to develop its "strategic approach" to countries wishing to improve the quality of reproductive health care they provide to their populations -- Tables -- 6.1. Numbers of HRP grants awarded to institutions during the 2000-2001 biennium, by region and type of grant -- 6.2. Numbers of researchers who received individual HRP research training grants during the 2000-2001 biennium, by sex, research area, and region -- Annex I: Financial overview for the biennium 2000-2001 -- Sources of income -- Figures -- I.1. Funds received in relation to approved budgets during 1988-2001 -- Tables -- I.1. HRP income, 1970-2001 -- Annex II: Centres collaborating with HRP during 2000-2001.

Annex III: HRP Staff, December 2001.